The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

1,249

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Colorectal Cancer
Interventions
DRUG

Methylene Blue MMX®

DRUG

Placebo

Sugar pill manufactured to mimic Methylene Blue MMX® tablet.

Trial Locations (19)

21287

Dr Marcia Canto, Baltimore

32224

Dr Michael Wallace, Jacksonville

55905

Dr David Bruining, Rochester

66103

Dr Prateek Sharma, Kansas City

80026

Dr David Gatof, Lafayette

85012

Dr Michelle Young, Phoenix

85259

Dr Francesco Ramirez, Scottsdale

Unknown

Dr Raf Bisschop, Leuven

Dr Ralf Kiesslich, Wiesbaden

Dr Renato Cannizzaro, Aviano

Dr Cesare Hassan, Rome

Dr Alessandro Repici, Rozzano

Dr Limas Kupcinskas, Kaunas

Dr Evelien Dekker, Amsterdam

Dr Manoon Spander, Rotterdam

Dr Peter Siersema, Utrecht

Dr James East, Oxford

Dr Matthew Rutter, Stockton-on-Tees

M5B 1W8

Dr Norman Marcon, Toronto

Sponsors
All Listed Sponsors
lead

Cosmo Technologies Ltd

INDUSTRY

NCT01694966 - The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy | Biotech Hunter | Biotech Hunter